Dr. Zand is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
17189 IH 45 South
Suite 205
Shenandoah, TX 77385Phone+1 936-270-4130Fax+1 936-270-4131
Summary
- I am a gynecologic oncologist at Houston Methodist Hospital in The Woodlands and West Houston. I specialize in surgery, chemotherapy, and immunotherapy for gynecologic cancers (ovarian, uterine, cervical, and vulva cancers). I have extensive minimally invasive surgical experience using both traditional laparoscopy and robotic surgery. I also specialize in caring for women with cervical dysplasia, vulva/vaginal dysplasia, and women with BRCA or Lynch Syndrome genetic mutations.
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 2011 - 2015
- University of Texas Graduate School of Biomedical SciencesM.S., Biomedical Science, 2011 - 2013
- Baylor College of MedicineResidency, Obstetrics and Gynecology, 2007 - 2011
- University of Nebraska College of MedicineClass of 2007
- University of Nebraska-LincolnBA, Chemistry, Psychology, 2003
Certifications & Licensure
- FL State Medical License 2021 - Present
- TX State Medical License 2013 - 2025
- OK State Medical License 2020 - 2021
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Baylor College of Medicine Arthur Faris Sr. M.D. Resident Research Abstract Winner - 2nd place Baylor College of Medicine Department of Obstetrics and Gynecology, 2009
- Baylor OB/GYN Outstanding Medical Student Educator Baylor College of Medicine Department of Obstetrics and Gynecology, 2007-2008
- Golden Key International Honor Society 2003-2007
- Join now to see all
Clinical Trials
- Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer Start of enrollment: 2015 Sep 23
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 125 citationsTherapeutic synergy between microRNA and siRNA in ovarian cancer treatment.Masato Nishimura, Eun-Jung Jung, Maitri Y. Shah, Chunhua Lu, Riccardo Spizzo
Cancer Discovery. 2013-11-01 - 232 citationsHematogenous Metastasis of Ovarian Cancer: Rethinking Mode of SpreadSunila Pradeep, Seung W. Kim, Sherry Y. Wu, Masato Nishimura, Pradeep Chaluvally-Raghavan
Cancer Cell. 2014-07-14 - 46 citationsImmunotherapy targeting folate receptor induces cell death associated with autophagy in ovarian cancerYunfei Wen, Whitney Graybill, Rebecca A. Previs, Wei Hu, Cristina Ivan
Clinical Cancer Research. 2015-01-15
Press Mentions
- Cervical Cancer Survivor: Why I Support the HPV VaccineAugust 8th, 2018
- Why Are Cancer Drugs More Expensive Than Ever?January 23rd, 2018
- Why Music Can Be Good MedicineMarch 28th, 2017
- Join now to see all
Professional Memberships
- Fellow
- Society of Gynecologic OncologyFellow
External Links
- Faculty Homepagehttps://www.houstonmethodist.org/doctor/behrouz-zand/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: